FASN and ovarian carcinoma: C75, an FASN inhibitor has more stable chemical properties than cerulenin, and also shows a strong inhibitory effect on a variety of human cancer cell lines, including breast cancer, prostate cancer, mesothelioma, and ovarian cancer.221